HER3 and Panitumumab Efficacy in Advanced Colorectal Cancer

This biomarker study examines the efficacy of irinotecan plus panitumumab in patients with advanced colorectal cancer whose tumors had high HER3 messenger RNA expression.

http://ift.tt/2y8nyN1